Clinical Trial Update: Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C [Phase 1]

View source ↗

Summary

Phase I safety and PK/PD study of lomitapide in Japanese and Caucasian subjects with elevated LDL-C completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elevated Low-density Lipoprotein Cholesterol
• Hyperlipidemia

Drugs mentioned

• Lomitapide (lomitapide)

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Healthy Volunteer | Phase 1 | Status: COMPLETED | Results posted: 2018-11-20